rs1801184

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000090.4(COL3A1):​c.2244T>C​(p.Gly748Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.272 in 1,594,368 control chromosomes in the GnomAD database, including 61,659 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.27 ( 5835 hom., cov: 31)
Exomes 𝑓: 0.27 ( 55824 hom. )

Consequence

COL3A1
NM_000090.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:17

Conservation

PhyloP100: -2.73
Variant links:
Genes affected
COL3A1 (HGNC:2201): (collagen type III alpha 1 chain) This gene encodes the pro-alpha1 chains of type III collagen, a fibrillar collagen that is found in extensible connective tissues such as skin, lung, uterus, intestine and the vascular system, frequently in association with type I collagen. Mutations in this gene are associated with Ehlers-Danlos syndrome type IV, and with aortic and arterial aneurysms. [provided by R. Dalgleish, Feb 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 2-188999856-T-C is Benign according to our data. Variant chr2-188999856-T-C is described in ClinVar as [Benign]. Clinvar id is 136853.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-188999856-T-C is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-2.72 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.295 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL3A1NM_000090.4 linkc.2244T>C p.Gly748Gly synonymous_variant Exon 32 of 51 ENST00000304636.9 NP_000081.2 P02461-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL3A1ENST00000304636.9 linkc.2244T>C p.Gly748Gly synonymous_variant Exon 32 of 51 1 NM_000090.4 ENSP00000304408.4 P02461-1
COL3A1ENST00000450867.2 linkc.2145T>C p.Gly715Gly synonymous_variant Exon 31 of 50 1 ENSP00000415346.2 H7C435

Frequencies

GnomAD3 genomes
AF:
0.272
AC:
41256
AN:
151874
Hom.:
5833
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.299
Gnomad AMI
AF:
0.405
Gnomad AMR
AF:
0.252
Gnomad ASJ
AF:
0.345
Gnomad EAS
AF:
0.0752
Gnomad SAS
AF:
0.159
Gnomad FIN
AF:
0.166
Gnomad MID
AF:
0.370
Gnomad NFE
AF:
0.292
Gnomad OTH
AF:
0.301
GnomAD2 exomes
AF:
0.234
AC:
51452
AN:
219808
AF XY:
0.235
show subpopulations
Gnomad AFR exome
AF:
0.298
Gnomad AMR exome
AF:
0.159
Gnomad ASJ exome
AF:
0.341
Gnomad EAS exome
AF:
0.0688
Gnomad FIN exome
AF:
0.178
Gnomad NFE exome
AF:
0.293
Gnomad OTH exome
AF:
0.274
GnomAD4 exome
AF:
0.272
AC:
392583
AN:
1442374
Hom.:
55824
Cov.:
35
AF XY:
0.270
AC XY:
192925
AN XY:
715132
show subpopulations
Gnomad4 AFR exome
AF:
0.304
AC:
10162
AN:
33404
Gnomad4 AMR exome
AF:
0.169
AC:
6840
AN:
40584
Gnomad4 ASJ exome
AF:
0.343
AC:
8792
AN:
25666
Gnomad4 EAS exome
AF:
0.0865
AC:
3391
AN:
39188
Gnomad4 SAS exome
AF:
0.160
AC:
13193
AN:
82480
Gnomad4 FIN exome
AF:
0.182
AC:
9489
AN:
52272
Gnomad4 NFE exome
AF:
0.292
AC:
322380
AN:
1103204
Gnomad4 Remaining exome
AF:
0.270
AC:
16158
AN:
59842
Heterozygous variant carriers
0
14968
29936
44905
59873
74841
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
10542
21084
31626
42168
52710
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.272
AC:
41273
AN:
151994
Hom.:
5835
Cov.:
31
AF XY:
0.264
AC XY:
19649
AN XY:
74304
show subpopulations
Gnomad4 AFR
AF:
0.299
AC:
0.299082
AN:
0.299082
Gnomad4 AMR
AF:
0.252
AC:
0.252064
AN:
0.252064
Gnomad4 ASJ
AF:
0.345
AC:
0.344758
AN:
0.344758
Gnomad4 EAS
AF:
0.0748
AC:
0.0747971
AN:
0.0747971
Gnomad4 SAS
AF:
0.158
AC:
0.158451
AN:
0.158451
Gnomad4 FIN
AF:
0.166
AC:
0.166321
AN:
0.166321
Gnomad4 NFE
AF:
0.292
AC:
0.291679
AN:
0.291679
Gnomad4 OTH
AF:
0.302
AC:
0.302083
AN:
0.302083
Heterozygous variant carriers
0
1545
3090
4635
6180
7725
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
412
824
1236
1648
2060
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.288
Hom.:
18275
Bravo
AF:
0.279
Asia WGS
AF:
0.152
AC:
527
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:17
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:8
-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Nov 20, 2014
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

p.Gly748Gly in exon 32 of COL3A1: This variant is not expected to have clinical significance because it does not alter an amino acid residue and is not located within the splice consensus sequence. It has been identified in 29% (2489/8596) of European American chromosomes and 28% (1217/4406) of African American chromos omes by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS/; d bSNP rs1801184). -

Nov 20, 2012
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Aug 05, 2016
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 01, 2019
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: COL3A1 c.2244T>C alters a non-conserved nucleotide resulting in a synonymous change. The variant allele was found at a frequency of 0.23 in 219808 control chromosomes in the gnomAD database, including 6705 homozygotes, strongly suggesting that the variant is benign. To our knowledge, no occurrence of c.2244T>C in individuals affected with Aortopathy and no experimental evidence demonstrating its impact on protein function have been reported. Three clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as benign. Based on the evidence outlined above, the variant was classified as benign. -

Apr 09, 2025
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, Montreal Heart Institute
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Ehlers-Danlos syndrome, type 4 Benign:4
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 23, 2022
Cohesion Phenomics
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jul 22, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Familial thoracic aortic aneurysm and aortic dissection Benign:2
Mar 15, 2018
Color Diagnostics, LLC DBA Color Health
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 24, 2014
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Nov 26, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Polymicrogyria with or without vascular-type Ehlers-Danlos syndrome Benign:1
Jul 22, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
5.2
DANN
Benign
0.60
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
Splicevardb
2.0
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1801184; hg19: chr2-189864582; COSMIC: COSV58593850; COSMIC: COSV58593850; API